How Much Did BranchLab Raise?
Funding & Key Investors

BranchLab has secured significant enterprise-level funding, with its total capital raised standing at $26M. The company recently announced a major strategic investment of $26M, underscoring its pivotal role in the data solutions sector. This latest financing round, which closed on May 12, 2026, marks a key milestone in BranchLab's growth trajectory.

What is BranchLab?

BranchLab
Business ServicesSoftware TestingAdvertising Networks

BranchLab operates as a privacy-first, AI-native data company. It specializes in providing HIPAA-compliant data solutions and predictive modeling for healthcare and pharmaceutical brands. The company's core mission is to enable these brands to effectively reach high-value audiences through advanced AI-driven insights, positioning itself as a critical player in the intersection of healthcare, data privacy, and artificial intelligence.

How much funding has BranchLab raised?

BranchLab has raised a total of $26M across 1 funding round:

2026

Series A

$26M

Series A (2026): $26M with participation from Sanofi Ventures, AIX Ventures, FCA Venture Partners, and McKesson Ventures

Key Investors in BranchLab

Sanofi Ventures

Sanofi Ventures is the corporate venture capital arm of Sanofi, focusing on early-stage biotech and digital health companies with innovative products and technologies of strategic interest to Sanofi, including oncology, immunology, and digital health solutions.

AIX Ventures

AIX Ventures is a venture capital firm dedicated to investing in seed-stage AI startups, aiming to support founders in transforming industries through innovative AI technologies and long-term collaboration.

FCA Venture Partners

FCA Venture Partners is an investment firm that transforms healthcare by backing companies enhancing patient care, empowering providers, and reducing costs, with expertise in providers, payers, pharma, and innovative care delivery.

What's next for BranchLab?

The substantial enterprise-level funding and recent strategic investment indicate that BranchLab is poised for significant scaling and market expansion. This capital infusion is expected to fuel further development of its AI-native predictive modeling capabilities and enhance its HIPAA-compliant data solutions. The company is likely to focus on deepening its penetration within the healthcare and pharmaceutical sectors, potentially exploring new strategic partnerships and technological advancements to solidify its leadership in privacy-first data analytics.

See full BranchLab company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesFood Service
Accounting for Legal PracticesBusiness Services
Business ServicesSoftware TestingHuman Resources Management Systems (HRMS)
Business ServicesCommercial PrintingAdvertising Networks

Frequently Asked Questions Regarding BranchLab Financial Insights

What are the most recent funding rounds that BranchLab has completed, and what were the funding rounds?
BranchLab has recently completed 1 funding rounds: Series A on May 12, 2026.
What is the total amount of funding BranchLab has raised to date?
BranchLab has raised a total of $26M in funding to date.
How many funding rounds has BranchLab completed?
BranchLab has completed 1 funding rounds.
How much funding did BranchLab raise in its most recent funding round?
BranchLab raised $26M in its most recent funding round.
Who are the lead investors in BranchLab's latest funding round?
The lead investor in BranchLab's latest funding round was Sanofi Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in BranchLab's history?
The largest funding round in BranchLab's history was $26M.
See more information about BranchLab